彻底改变结核病治疗:突破,挑战和希望在地平线上
Martin Kufa1,2, Vladimir Finger1,2, Ondrej Kovar1,2
1Faculty of Pharmacy in Hradec Kralové, Charles University, Hradec Kralove 50003, Czech Republic.
Acta pharmaceutica Sinica. B
|May 15, 2025
概括
结核病 (TB) 仍然是一个全球性的健康威胁,每年有数百万人受到影响. 开发新药对于对抗耐药菌株和改善治疗结果至关重要,尽管存在研究资金挑战.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由Mycobacterium tuberculosis (Mtb) 引起的结核病 (TB) 在2022年导致130万人死亡.
- 目前的多药疗法需要六个月的每日剂量,往往导致治疗失败和耐药结核病的增加.
- 耐药结核病带来复杂而昂贵的治疗挑战.
研究的目的:
- 审查最近在抗结核病药物发现方面的进展.
- 突出开发新型抗结核病疗法的挑战和机遇.
- 强调在打击结核病方面需要继续进行研究和合作.
主要方法:
- 关于抗结核病药物发现的最新科学文献的综述.
- 对当前结核病治疗环境和耐药性趋势的分析.
- 检查新的抗结核病候选药物的管道.
主要成果:
- 一些有前途的药物 (bedaquiline,delamanid, pretomanid) 已经获得批准,有19种候选药物正在临床试验中.
- 开发具有独特抗MTB作用机制的新药仍然具有挑战性.
- 结核病研究资金不足,需要学术和私营部门的合作.
结论:
- 尽管取得了进展,但仍需要具有新型机制的有效和安全的抗结核病药物.
- 合作对于加速抗结核药物开发和解决资金缺口至关重要.
- 反结核病药物发现的动态景观为改善全球健康结果提供了希望.
更多相关视频
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.7K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.7K
相关概念视频
01:28Pulmonary Tuberculosis V
157
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
157
01:26Pulmonary Tuberculosis IV
125
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
125
01:29Pulmonary Tuberculosis I
210
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
210
01:28Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
01:31Pulmonary Tuberculosis III
277
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
277
01:20COPD: Pathogenesis and Clinical Features
206
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
206